XML 53 R35.htm IDEA: XBRL DOCUMENT v3.24.4
SHARE BASED COMPENSATION (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
SCHEDULE OF EXERCISE PRICES AND REMAINING CONTRACTUAL LIVES OF OUTSTANDING OPTIONS

The following is information regarding exercise prices and remaining contractual lives of outstanding options as of June 30, 2024:

 

June 30, 2024 
outstanding   Exercisable 

Number of

options

outstanding

  

Exercise price

range (USD)

  

Weighted

average

remaining

contractual life

  

Number of

options

Exercisable

  

Exercise price

range (USD)

  

Weighted

average

remaining

contractual life

 
 40,654    3.22    9.1    -    -    - 
 37594    4.23    8.7    11,751    4.23    8.7 
 9,617    4.63    8.5    3,525    4.63    8.5 
 13,115    4.71    8.6    4,099    4.71    8.6 
 48,222    5.74    8.0    24,863    5.74    8.0 
 85,247    7.12    8.2    39,346    7.12    8.2 
 75,309    7.57    3.5    75,309    7.57    3.5 
 46,048    7.61    8.8    46,048    7.61    8.8 
 238,340    7.82    6.3    238,340    7.82    6.3 
 36,931    8.73    8.8    -    -    - 
 36,931    11.35    8.8    -    -    - 
 78,336    15.63    6.3    68,793    15.63    6.3 
 19,235    17.47    7.3    15,957    17.47    7.3 
 765,579    8.14    7.8    528,031    8.25    9.37 

The following is information regarding exercise prices and remaining contractual lives of outstanding options at December 31, 2023:

 

 

December 31, 2023 
Outstanding   Exercisable 

Number of

options

outstanding

  

Exercise

price (USD)

  

Weighted

average

remaining

contractual life

  

Number of

options

Exercisable

  

Exercise

price (USD)

  

Weighted

average

remaining

contractual life

 
49,400    3.32    9.6    -    -    - 
39,782    4.35    9.2    -    -    - 
9,618    4.80    8.9    2,077    4.80    8.9 
13,115    4.92    9.1    -    -    - 
59,482    5.95    8.5    19,809    5.95    8.5 
96,177    7.43    8.7    28,416    7.43    8.7 
46,050    7.89    9.3    -    -    - 
46,050    9.04    9.3    -    -    - 
46,050    11.78    9.3    -    -    - 
22,733    18.07    7.8    13,989    18.07    7.8 
428,457    7.55    8.9    64,291    9.15    8.2 
SCHEDULE OF CHANGES IN FAIR VALUE OF OPTIONS

The table below sets forth a summary of changes in the fair value of the options:

 

  

Number of

options measured

at fair value

  

Fair value

(U.S. Dollars in

thousands)

 
Balance as of December 31, 2023   405,714    232 
Effect of change in exchange rate   -    (4)
Changes in fair value   -    74 
Reclassification of liability classified share-based compensation awards to equity   (401,794)   (302)
Balance as of June 30, 2024   -    - 

The table below sets forth a summary of changes in the fair value of the options:

 

 

  

Number of options

measured at

fair value

  

Fair value

(U.S. Dollars

in thousands)

 
Balance at January 1, 2021   446,703    4,769 
Effect of change in exchange rate   -     112 
Changes in fair value   -    (1,276)
Reclassification of liability classified share-based compensation awards to equity   (401,794)   (302)
Balance at December 31, 2021   446,703    3,605 
Effect of change in exchange rate        (315)
Changes in fair value   -    (2,294)
Balance at December 31, 2022   440,045    996 
Effect of change in exchange rate        (30)
Changes in fair value   -    (734)
Balance at December 31, 2023   405,714    232 
SCHEDULE OF EXPENSE (INCOME) RECOGNIZED IN CONSOLIDATED FINANCIAL STATEMENTS

The table below presents the expense (income) recognized in the financial statements of the Company in respect to share-based payment:

 

   Six months ended June 30 
   2024   2023 
  

Equity

classified

awards

  

Liability

classified

awards

  

Total

expense

  

Equity

classified

awards

  

Liability

classified

awards

  

Total

expense

 
Cost of revenue   -    -    -    (19)   (5)   (24)
Research and development expenses (income)   67    41    108    103    (116)   (13)
Sales and marketing expenses (income)   51    20    71    46    (21)   25 
General and Administrative expenses   72    13    85    150    3    153 
    190    74    264    280    (139)   141 

The table below presents the expense (income) recognized in the financial statements of the Company in respect to share-based payment:

 

   Year ended December 31 
   2022  2021 
   Equity
classified
awards
   Liability
classified
awards
   Total
expense
   Equity
classified
awards
   Liability
classified
awards
   Total
expense
 
Research and development expenses (income)   206    (1,426)   (1,220)   7    (1,297)   (1,290)
Sales and marketing expenses (income)   59    (546)   (487)   269    (459)   (190)
General and Administrative expenses (income)   278    (322)   (44)   70    95    165 
    543    (2,294)   (1,751)   346    (1,661)   (1,315)

 

 

ZOOZ POWER LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (continued)

 

   Year ended December 31 
   2023 
   Equity classified
awards
   Liability
classified awards
   Total
expense
 
Research and development expenses (income)   98    (440)   (342)
Sales and marketing expenses (income)   111    (171)   (60)
General and Administrative expenses (income)   294    (111)   183 
    503    (722)   (219)

 

Equity Classified Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
SCHEDULE OF FAIR VALUE ASSUMPTIONS

 

   June 30,
2024
   December 31,
2023
 
Dividend yield   0%   0%
Expected volatility*   

55%-89

%   

74%-76

%
Risk-free interest rate   

3.3%-5.8

%   

3.3%-3.9

%
Expected term (years)   

2-7 years

    

4-7 years

 
Exercise price (USD)   

3.32-15.45

    

3.32-11.78

 

 

*Volatility is based on the historical fluctuation in share prices of peer companies over similar periods to the expected life of the option until exercise date.

 

   2023   2022   2021 
Dividend yield   0%   0    0%
Expected volatility   74%-76%      52%-76%    55%-75%   
Risk-free interest rate   3.3%-3.9%      2.4%-3.1%    0.75%-2%   
Expected term (years)   4-7 years      5-7 years    5-6 years   
Exercise price (USD)   3.32-11.78      4.92-7.55    5.15-21.16   
SCHEDULE OF STOCK OPTIONS ACTIVITY

The following is summary information of equity classified options in 2023:

 

  

Six months ended

June 30, 2024

 
     

Weighted

average

exercise price

  

Weighted

average

remaining

contractual life

  

Aggregate

Intrinsic

 
   Number   USD   years       Value 
Outstanding as of December 31, 2023   428,457    7.55    8.9    - 
Forfeited   (64,672)   10.5    6.9    - 
Reclassification of liability classified
share-based compensation awards to equity
   401,794    9.32    5.7    - 
Outstanding as of June 30, 2024   765,579    8.31    7.1    - 
Exercisable as of June 30, 2024   528,031    8.80    6.5    - 

The following is summary information of equity classified options in 2023:

 

   Year ended December 31, 2023 
      

Weighted

average

exercise

price

  

Weighted

average

remaining

contractual

life

  

Aggregate

Intrinsic

 
   Number   USD   Years   Value 
Outstanding at beginning of year   298,955    8.46    9.4         - 
Expired   (110,945)   16.81    -    - 
Granted   240,447    5.60    9.3    - 
Forfeited   (64,672)   10.5    6.9    - 
Reclassification of liability classified
share-based compensation awards to equity
   401,794    9.32    5.7    - 
Outstanding at end of year   428,457    7.55    8.9    - 
Exercisable at end of year   64,291    9.15    8.2    - 
Liability Classified Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
SCHEDULE OF FAIR VALUE ASSUMPTIONS

The following table summarizes assumptions used as of December 31, 2023:

 

   December 31,
2023
 
Expected dividend   0%
Expected volatility   

81.2%-90.9

%
Risk-free interest rate   

4.97%-5.35

%
Expected life   

2-4

 
Exercise price (USD)   

4.57-15.67

 

The following table summarizes assumptions used as of December 31, 2023, 2022 and 2021:

 

   2023   2022   2021 
Expected dividend   0%   0%   0%
Expected volatility*   81.2%-90.9%    79.6%-95.7%    86.9%-95% 
Risk-free interest rate   4.97%-5.35%    4.68%-5.27%    1.18%-1.87% 
Expected life   2-4    1.5-5    2-5.9 
Exercise price (USD)   4.57-15.67    4.57-15.67    4.57-15.67 
SCHEDULE OF STOCK OPTIONS ACTIVITY  

The following is summary information about liability classified options in 2023:

 

   Year ended December 31, 2023 
       Weighted
average
exercise
price
   Weighted
average
remaining
contractual
life
   Aggregate
Intrinsic
 
   Number   USD   years   Value 
Outstanding at beginning of year   440,045    8.46    6.3    - 
Expired   (34,331)   7.66    -    - 
Outstanding at end of year   405,714    9.72    6.2    - 
Exercisable at end of year   386,016    10.52    6.1    - 
SCHEDULE OF EXERCISE PRICES AND REMAINING CONTRACTUAL LIVES OF OUTSTANDING OPTIONS  

The following is information regarding exercise prices and remaining contractual lives of outstanding options at December 31, 2023:

 

December 31, 2023 
outstanding   Exercisable 
Number of
options
outstanding
   Exercise price
range (USD)
   Weighted
average
remaining
contractual life
   Number of
options
Exercisable
   Exercise price
range (USD)
   Weighted
average
remaining
contractual life
 
78,110    7.55    4.1    78,110    7.55    4.1 
239,009    7.78    6.8    239,009    7.78    6.8 
78,795    15.67    6.9    59,097    15.67    6.9 
9,800    25.62    0.4    78,110    25.62    0.4 
405,714    9.72    6.2    386,016    10.52    6.1